Precision probiotics firm Biome Australia says that giving practitioners a foundational understanding of microbiome modulation, before reinforcing efficacy via clinical trials, will be key to its ongoing growth objectives in the market.
An amino acid based infant formula with synbiotics could help infants allergic to cow’s milk develop tolerance, restore disrupted gut microbiota, and lower their risk of hospitalisation due to infections.
